Cargando…
Biologic Concentration Testing in Inflammatory Bowel Disease
Anti-TNF medications have revolutionized the care of patients with inflammatory bowel disease. However, despite an initial robust effect, loss of response is common and long-term results are disappointing. Much of this lack of durability may be due to inadequate dose optimization, and recent studies...
Autores principales: | Vaughn, Byron P., Sandborn, William J., Cheifetz, Adam S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437804/ https://www.ncbi.nlm.nih.gov/pubmed/25590953 http://dx.doi.org/10.1097/MIB.0000000000000312 |
Ejemplares similares
-
Drug Clearance in Patients with Inflammatory Bowel Disease Treated with Biologics
por: Deyhim, Tina, et al.
Publicado: (2023) -
Vedolizumab Serum Trough Concentrations and Response to Dose Escalation in Inflammatory Bowel Disease
por: Vaughn, Byron P., et al.
Publicado: (2020) -
A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease
por: Vaughn, Byron P.
Publicado: (2021) -
Infliximab in inflammatory bowel disease
por: Papamichael, Konstantinos, et al.
Publicado: (2019) -
A primer on common supplements and dietary measures used by patients with inflammatory bowel disease
por: Minhas, Hadi J, et al.
Publicado: (2023)